Expanded Indications for Hodgkin and CLL Drugs in Europe ...Middle East

The EMA has recommended extensions to the marketing authorizations for Adcetris, used to treat Hodgkin lymphoma, and Calquence, indicated for chronic lymphocytic leukemia. Medscape Medical News

Hence then, the article about expanded indications for hodgkin and cll drugs in europe was published today ( Thursday 01/05/2025 - 06:10 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Expanded Indications for Hodgkin and CLL Drugs in Europe )

Also on site :

• UN renews Sudan ceasefire appeal over ‘unimaginable suffering’ of civilians
• Central African Republic election: Who’s running and what’s at stake?
• Israeli forces continue ceasefire violations with attacks across Gaza